RSC Medicinal Chemistry

Discovery of a novel pyrimidine derivative for treatment of acute lung injury through reducing oxidative stress and inflammatory response

发现一种新型嘧啶衍生物，可通过减少氧化应激和炎症反应治疗急性肺损伤

AlbiCDN: albumin-binding amphiphilic STING agonists augment the immune activity for cancer immunotherapy

AlbiCDN：白蛋白结合两亲性 STING 激动剂增强癌症免疫治疗的免疫活性

Development of small-molecule fluorescent probes targeting neutrophils via N-formyl peptide receptors

通过 N-甲酰肽受体靶向中性粒细胞的小分子荧光探针的开发

Discovery of isoquinoline-tethered quinazoline derivatives with enhanced HER2 inhibition over EGFR

发现异喹啉束缚喹唑啉衍生物，其对 HER2 的抑制作用优于 EGFR

Design, synthesis and in vitro evaluations of new cyclotriphosphazenes as safe drug candidates

新型环三磷腈作为安全候选药物的设计、合成及体外评估

Application of a bivalent "click" approach to target tyrosyl-DNA phosphodiesterase 1 (TDP1)

应用二价“点击”方法靶向酪氨酰 DNA 磷酸二酯酶 1 (TDP1)

Salicylamide derivatives as potent HBV inhibitors: insights into structure-activity relationships.

Design, synthesis and biological evaluation of novel bis(indolyl)-tetrazine derivatives as anti-breast cancer agents.

A context-based matched molecular pair analysis identifies structural transformations that reduce CYP1A2 inhibition.

SIGMAP: an explainable artificial intelligence tool for SIGMA-1 receptor affinity prediction.